Glisoxepide

ALIMENTARY TRACT AND METABOLISM

Key facts

Glisoxepide is a drug catalogued in DrugCentral. DrugCentral lists 1 molecular target, including ABCC8|KCNJ11. Recorded indications include Diabetes mellitus type 2.

• Molecular targets: ABCC8|KCNJ11 (1 listed in DrugCentral).
• Indications: Diabetes mellitus type 2.
• ATC code: A10BB11 (Sulfonylureas).
• Molecular formula: C20H27N5O5S; molecular weight 449.53 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

• Diabetes mellitus type 2

Mechanism & targets

Molecular targets (1)

Target	Gene	Action	Activity
Sulfonylurea receptor 1, Kir6.2	ABCC8|KCNJ11	blocker	Kd 7.96

ATC classification

ATC code	Therapeutic hierarchy
A10BB11	ALIMENTARY TRACT AND METABOLISM › DRUGS USED IN DIABETES › BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS › Sulfonylureas

Chemical structure

• Molecular formula: C₂₀H₂₇N₅O₅S
• Molecular weight: 449.53 g/mol
• CAS number: 25046-79-1
• InChIKey: ZKUDBRCEOBOWLF-UHFFFAOYSA-N
• PubChem CID: 32778

CC1=CC(=NO1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN1CCCCCC1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Glisoxepide used for?

DrugCentral lists the following indications for Glisoxepide: Diabetes mellitus type 2.

How does Glisoxepide work?

Its molecular targets in DrugCentral include ABCC8|KCNJ11 (blocker).

What is the chemical formula of Glisoxepide?

Glisoxepide has the molecular formula C20H27N5O5S and a molecular weight of 449.53 g/mol.

Sources

• DrugCentral drug card 1305 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL2106618 — compound record and bioactivity
• PubChem CID 32778 — chemical identifiers
• DrugBank DB01289 — drug record
• FDA UNII H7SC0I332I — substance identity

How this page is built: methodology · editorial policy & corrections.